Thank you. I'm pleased to say that Sonia Sidhu is on our committee and is here today, so I appreciate my colleague's action on that. I think we could potentially take that as a recommendation from this study.
My next question is for Ms. Boucher. I just want to pick up on something you said the U.K. Parliament is looking at, which is the “de-prescribing”, the withdrawal, because we heard in previous testimony that often when young girls present at emergency, they're given medication and they're sent home, and then there's no follow-up. Some of this can be very difficult to withdraw from.
You said there were lessons to be learned there for Canada. Could you maybe, in a very short time, elaborate on what those lessons might be?